| Human natural killer cells mediate adaptive immunity to viral antigens R Nikzad, LS Angelo, K Aviles-Padilla, DT Le, VK Singh, L Bimler, ... Science immunology 4 (35), eaat8116, 2019 | 169 | 2019 |
| Macrophage heterogeneity and plasticity in tuberculosis A Khan, VK Singh, RL Hunter, C Jagannath Journal of leukocyte biology 106 (2), 275-282, 2019 | 118 | 2019 |
| Increased virulence of Mycobacterium tuberculosis H37Rv overexpressing LipY in a murine model VK Singh, M Srivastava, A Dasgupta, MP Singh, R Srivastava, ... Tuberculosis 94 (3), 252-261, 2014 | 45 | 2014 |
| Increased phagocytosis of Mycobacterium marinum mutants defective in lipooligosaccharide production: a structure-activity relationship study L Alibaud, J Pawelczyk, L Gannoun-Zaki, VK Singh, Y Rombouts, ... Journal of Biological Chemistry 289 (1), 215-228, 2014 | 43 | 2014 |
| Emerging prevention and treatment strategies to control COVID-19 VK Singh, A Mishra, S Singh, P Kumar, M Singh, C Jagannath, A Khan Pathogens 9 (6), 501, 2020 | 29 | 2020 |
| A unique PE_PGRS protein inhibiting host cell cytosolic defenses and sustaining full virulence of Mycobacterium marinum in multiple hosts VK Singh, L Berry, A Bernut, S Singh, S Carrère‐Kremer, A Viljoen, ... Cellular Microbiology 18 (11), 1489-1507, 2016 | 26 | 2016 |
| GM-CSF Dependent Differential Control of Mycobacterium tuberculosis Infection in Human and Mouse Macrophages: Is Macrophage Source of GM-CSF Critical to … A Mishra, VK Singh, JK Actor, RL Hunter, C Jagannath, S Subbian, ... Frontiers in immunology 11, 1599, 2020 | 25 | 2020 |
| A recombinant bovine adenoviral mucosal vaccine expressing mycobacterial antigen-85B generates robust protection against tuberculosis in mice A Khan, EE Sayedahmed, VK Singh, A Mishra, S Dorta-Estremera, ... Cell Reports Medicine 2 (8), 2021 | 23 | 2021 |
| 2, 3-Dideoxy hex-2-enopyranosid-4-uloses as promising new anti-tubercular agents: Design, synthesis, biological evaluation and SAR studies M Saquib, I Husain, S Sharma, G Yadav, VK Singh, SK Sharma, P Shah, ... European journal of medicinal chemistry 46 (6), 2217-2223, 2011 | 23 | 2011 |
| Human M1 macrophages express unique innate immune response genes after mycobacterial infection to defend against tuberculosis A Khan, K Zhang, VK Singh, A Mishra, P Kachroo, T Bing, JH Won, A Mani, ... Communications Biology 5 (1), 480, 2022 | 21 | 2022 |
| Manipulation of BCG vaccine: a double-edged sword VK Singh, R Srivastava, BS Srivastava European Journal of Clinical Microbiology & Infectious Diseases 35, 535-543, 2016 | 21 | 2016 |
| A new dehydratase conferring innate resistance to thiacetazone and intra‐amoebal survival of Mycobacterium smegmatis S Carrère‐Kremer, M Blaise, VK Singh, L Alibaud, E Tuaillon, I Halloum, ... Molecular microbiology 96 (5), 1085-1102, 2015 | 20 | 2015 |
| Overexpression of Rv3097c in Mycobacterium bovis BCG abolished the efficacy of BCG vaccine to protect against Mycobacterium tuberculosis infection in mice VK Singh, V Srivastava, V Singh, N Rastogi, R Roy, AK Shaw, AK Dwivedi, ... Vaccine 29 (29-30), 4754-4760, 2011 | 20 | 2011 |
| NOD2/RIG-I Activating Inarigivir Adjuvant Enhances the Efficacy of BCG Vaccine Against Tuberculosis in Mice A Khan, VK Singh, A Mishra, E Soudani, P Bakhru, CR Singh, D Zhang, ... Frontiers in Immunology 11, 592333, 2020 | 17 | 2020 |
| Multi-OMICs analysis reveals metabolic and epigenetic changes associated with macrophage polarization ML Sowers, H Tang, VK Singh, A Khan, A Mishra, BI Restrepo, ... Journal of Biological Chemistry 298 (10), 2022 | 12 | 2022 |
| Human mesenchymal stem cell based intracellular dormancy model of Mycobacterium tuberculosis VK Singh, A Mishra, S Bark, A Mani, S Subbian, RL Hunter, C Jagannath, ... Microbes and infection 22 (9), 423-431, 2020 | 11 | 2020 |
| Human monocyte-derived macrophage responses to M. tuberculosis differ by the host's tuberculosis, diabetes or obesity status, and are enhanced by rapamycin BI Restrepo, A Khan, VK Singh, E de-Leon, GP Aguillón-Durán, ... Tuberculosis 126, 102047, 2021 | 9 | 2021 |
| CD44 receptor targeted nanoparticles augment immunity against tuberculosis in mice VK Singh, E Chau, A Mishra, A DeAnda, VL Hegde, JK Sastry, D Haviland, ... Journal of Controlled Release 349, 796-811, 2022 | 7 | 2022 |
| Antibody-Mediated LILRB2-Receptor Antagonism Induces Human Myeloid-Derived Suppressor Cells to Kill Mycobacterium tuberculosis VK Singh, A Khan, Y Xu, S Mai, L Zhang, A Mishra, BI Restrepo, PY Pan, ... Frontiers in Immunology 13, 865503, 2022 | 6 | 2022 |
| B cells are required to generate optimal anti-melanoma immunity in response to checkpoint blockade S Singh, J Roszik, N Saini, VK Singh, K Bavisi, Z Wang, LT Vien, Z Yang, ... Frontiers in immunology 13, 794684, 2022 | 6 | 2022 |
